Target intelligence / Profile preview

Ras-like GTPase (Ral)

Target
Ral
Molecular classification
Small GTPase, Ras superfamily, Enzyme
01

Overview

Ras-like GTPases (RalA and RalB) are small G proteins belonging to the Ras superfamily that function as critical molecular switches in intracellular signaling (UniProt P11233, P11234). They are primarily activated by Ral guanine nucleotide exchange factors (RalGEFs), which are major downstream effectors of the Ras oncogene (Gentry et al., 2014, Cancer Research). Ral GTPases regulate diverse cellular processes, including receptor endocytosis, exocytosis via the exocyst complex, and actin cytoskeletal remodeling (Neigeborn et al., 2021, Journal of Cell Science). In the context of human disease, Ral signaling is frequently hijacked in various malignancies, particularly those with KRAS mutations, where it drives tumor growth, survival, and metastatic progression (Yan et al., 2014, Nature). Consequently, Ral GTPases have emerged as promising therapeutic targets, with research focusing on small molecules like RBC8 and BQU57 that disrupt their activation or their binding to essential effector proteins (Yan et al., 2014, Nature).

Other names
Ras-related protein Ral-ARas-related protein Ral-BRalARalB
02

Mechanism of action

Inhibition of the interaction between Ral GTPases and their downstream effectors (such as the exocyst complex) or inhibition of the activation of Ral by RalGEFs (Yan et al., 2014, Nature; Gentry et al., 2014, Cancer Research).

03

Biological functions

Signal transductionVesicle traffickingCell proliferationCytoskeletal organizationExocytosisCell migration
04

Disease associations

CancerMetastasisPancreatic cancerNon-small cell lung cancerColorectal cancer
05

Safety considerations

Potential interference with normal exocytosis and vesicle transport (Gentry et al., 2014, Cancer Research)Off-target effects on other Ras superfamily membersLimited clinical data on systemic toxicity
06

Interacting drugs

RBC8

2 more in the full profile.

07

Biomarkers

RalA expressionRalB expressionRal-GTP levelsKRAS mutation status

Beyond the preview

Go deeper on Ras-like GTPase (Ral).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-like GTPase (Ral).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call